Compare AAT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAT | PAHC |
|---|---|---|
| Founded | 1967 | 1946 |
| Country | United States | United States |
| Employees | 208 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2010 | 2014 |
| Metric | AAT | PAHC |
|---|---|---|
| Price | $23.61 | $32.76 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $19.50 | ★ $41.25 |
| AVG Volume (30 Days) | 352.0K | ★ 486.2K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.65% | 0.91% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | 0.08 | ★ 1.90 |
| Revenue | $436,204,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $4.33 | $17.03 |
| Revenue Next Year | $0.22 | $3.82 |
| P/E Ratio | $298.25 | ★ $17.39 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $17.72 | $22.85 |
| 52 Week High | $23.97 | $60.08 |
| Indicator | AAT | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 74.07 | 36.35 |
| Support Level | $18.23 | N/A |
| Resistance Level | N/A | $34.98 |
| Average True Range (ATR) | 0.53 | 1.55 |
| MACD | 0.12 | 0.56 |
| Stochastic Oscillator | 87.95 | 60.01 |
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.